Anate Brauer, M.D.

Board Certified Board Certified

  • Obstetrics and Gynecology
  • Reproductive Endocrinology and Infertility
Patient Testimonial
Without question, Dr. Anate Brauer is the best of the best. If you’re looking for a committed partner, caring supporter and engaged doctor – she’s an obvious winner!

She was warm, kind, compassionate, and sincere. Dr. Brauer’s dedication to helping people get pregnant is evident.

From the get go I felt like Dr. Brauer was the right doctor for me. Her personality made me want to grab a cup of coffee with her yet her brilliance was evident.

Dr. Brauer’s upbeat attitude told me that even if we had a setback, she’d have a plan b and another path to success.

Dr. Brauer has a great bedside manner. She seems to really focus on individualized care and not just applying the status quo.

Dr. Brauer made the experience of starting our family an amazing journey. She was compassionate about our “two mommy” home and supportive of our journey.

Biography

Anate A. Brauer, M.D., FACOG, is a board-certified reproductive endocrinologist with extensive experience in treating all medical and surgical aspects of infertility. She serves as SGF New York’s IVF Director.

Dr. Brauer earned her medical degree from the George Washington University School of Medicine, where she was elected to the prestigious Alpha Omega Alpha medical honor society. She completed her residency in Obstetrics and Gynecology at New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Brauer subsequently completed her fellowship training in Reproductive Endocrinology and Infertility at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine and Infertility-Weill Cornell Medical College. Prior to joining Shady Grove Fertility, Dr. Brauer was an Assistant Clinical Professor at NYU School of Medicine.

Dr. Brauer has expertise in ovulation induction, in vitro fertilization (IVF), egg freezing, pre-implantation genetic testing and third-party reproduction including donor egg, donor sperm, donor embryo, and gestational surrogacy. She applies the latest clinical data, state-of-the-art technology, and extensive clinical experience to optimize pregnancy rates while minimizing patient stress with her supportive approach to care.

Dr. Brauer has published and presented at numerous national meetings on the topics of optimizing fertility treatments in patients with diminished ovarian reserve, polycystic ovarian syndrome (PCOS), or those using a gestational surrogate; fertility preservation; and complementary therapies in infertility. She is especially passionate about helping young patients with cancer build families, which has led her to serve on the Advisory Board of the Young Survivors Coalition. Dr. Brauer is a regular contributor on a variety of women’s health topics to local and national media such as Parents, Reader’s Digest, Refinery 29, Woman’s Health Magazine, Byrdie and Shape, to name a few. For Shape, she serves on their expert Brain Trust.

She is a fellow of the American Congress of Obstetrics and Gynecology and an active member of the American Society for Reproductive Medicine and the Fertility Preservation Special Interest Group.

Dr. Brauer enjoys spending time with her husband and their three children. She also enjoys cooking and running or spinning for exercise in her free time.

Dr. Brauer, who is also fluent in Hebrew, joined SGF in 2019, and sees patients at SGF’s New York office, located in the heart of Manhattan.

Read More

Education

  • Residency: Obstetrics and Gynecology, Weill Cornell Medical Center
  • Fellowship: Reproductive Endocrinology and Infertility, Weill Cornell Medical College
  • New York Super Doctors (2023)
  • Castle Connolly Top Doctor (2022-2023)
  • Resident Achievement Award, Society of Laparoendoscopic Surgeons
  • Rachel Morris Dominick Award in Obstetrics and Gynecology
  • Alpha Omega Alpha Honor Medical Society
  • Kane-King-Dodeck Obstetrical Honor Society
  • Alec Horwitz First Year Scholar Award
  • Mortar Board Senior Honor Society
  • American Congress of Obstetricians and Gynecologists
  • American Society for Reproductive Medicine
  • Society of Laparoendoscopic Surgeons
  • Westchester OBGYN Society
  • Kedem A, Aelion Brauer A (equal contributor), Guo P, Wen D, Ding B, Lis R Vladislav M, Raffi S, Rosenwaks Z. Activated ovarian endothelial cells promote early follicular development and survival. Journal of Ovarian Research 2017 10:64
  • Pereira N, Brauer AA, Melnick AP, Lekovich JP, Spandorfer SD. Prognostic value of growth of 4-cell embryos on the day of transfer in fresh IVF-ET cycles. Journal of Assisted Reproduction and Genetics 2015
  • Mok-Lin E, Aelion Brauer A, Schattman G, Zaninovic N, Rosenwaks Z, Spandorfer S Follicular flushing and in vitro fertilization outcomes in the poorest responders: a randomized controlled trial. Human Reproduction 2013 Nov;28(11):2990-5.
  • Reichman D, Aelion Brauer A, Goldschlag D, Schattman G, Rosenwaks Z. IVF for Orthodox Jewish Couples: Antagonist Cycle Modifications Allowing for Observance of Mikveh Prior to Oocyte Retrieval. Fertility and Sterility 2013 Jan ; 282(12)02462-4.
  • Jhaveri KD, Aelion A, Wanchoo R.Pre-eclampsia Presenting as Hyponatremia. Clinical Nephrology 2009 Dec; 72(6):492-6.
  • Worley M., Aelion A, Slomovitz B, Kuo DY, Kent K, Goldstein M, Caputo T. Intravenous Leiomyomatosis with Intracardiac Extension: A Single Institution Experience. American Journal of Obstetrics and Gynecology 2009 Dec; 201(6):574.
  • Aelion Brauer A, Kedem A, Guo P, Lis R, Rafii S, Rosenwaks Z. Isolation and characterization of ovarian endothelial cells (ECs): A novel tool in understanding the role of ovarian endothelial cells in reproductive biology. Oral Presentation at the American Society for Reproductive Medicine Annual Meeting Boston, MA October 2013. Fertil Steril 2013; 100 (3 Suppl): O199.
  • Aelion Brauer A, Kedem A, Guo P, Wen,D, Ding BS, Liu HC, Rafii S, Rosenwaks Z. Endothelial Derived Growth Signals Promote Growth and Survival of Early Follicles: An Ex-Vivo Model. Poster Presentation at the American Society for Reproductive Medicine Annual Meeting Boston, MA October 2013. Fertil Steril 2013; 100 (3 Suppl): P678.
  • Aelion Brauer A, Kedem A, Guo P, Wen D, Ding BS, Liu HC, Rafii S, Rosenwaks Z. Activated Ovarian Endothelial Cells Promote Early Follicular Development and Survival. Oral presentation at the Society for Gynecologic Investigation Annual Meeting, Orlando FL, March, 2013. Reprod Sci 2013; 20(3 Suppl): O13.
  • Aelion Brauer A, Mok-Lin E, Melnick, AP, Spandorfer S, Rosenwaks Z. Very Low Anti-Mullarian Hormone (AMH): Is it worth attempting In Vitro Fertilization (IVF)? Poster presentation at the Society for Gynecologic Investigation Annual Meeting, Orlando FL, March, 2013. Reprod Sci 2013; 20(3 Suppl): F131.
  • Aelion Brauer A, Mok-Lin E, Spandorfer S, Rosenwaks Z. Live birth chances in women with undetectable anti-Mullerian hormone (AMH) levels. Oral presentation at the American Society for Reproductive Medicine Annual Meeting, San Diego, CA, October 2012. Fertil Steril 2012; 98(3 Suppl): S77.
  • Noel M, Aelion Brauer A, Spandorfer, S. Do cghanges in the endometrial lining during In Vitro Fertilization (IVF) cycles predict pregnancy outcomes? Poster presentation at the Society for Gynecologic Investigation Annual Meeting, Orlando FL, March, 2013. Reprod Sci 2013; 20(3 Suppl): F144
  • Aelion Brauer A, Mok-Lin E, Spandorfer S, Rosenwaks Z. Chances of pregnancy at extreme of age: Does anti-Mullerian hormone (AMH) matter? Poster presentation at the American Society for Reproductive Medicine Annual Meeting, San Diego, CA, October 2012. Fertil Steril 2012; 98(3 Suppl): S199.
  • Mok-Lin E, Aelion Brauer A, Schattman G, Spandorfer S, Rosenwaks Z. Follicular flushing in very poor responders: A randomized controlled trial. Oral presentation at the American Society for Reproductive Medicine Annual Meeting, San Diego, CA, October 2012. Fertil Steril 2012; 98(3 Suppl): S57.
  • Mok-Lin E, Aelion Brauer A, Owen Davis, Zev Rosenwaks. Outcomes of protracted IVF cycles in poor responders undergoing clomiphene citrate protocols. Poster presentation at the American Society for Reproductive Medicine Annual Meeting, San Diego, CA, October 2012. Fertil Steril 2012; 98(3 Suppl): S175.
  • Mok-Lin E, Aelion Brauer A, Davis O, Rosenwaks Z. A thickened endometrial stripe on day 2 of OCP-priming protocols does not affect IVF outcomes. Poster presentation at the Pacific Coast Reproductive Society Annual Meeting, Rancho Mirage, CA, April 18-22, 2012. Fertil Steril 2012; 97(3 Suppl): S11.
  • Mok-Lin E, Aelion Brauer A, Davis O, Rosenwaks Z. A thickened endometrial stripe on day 2 of estrogen-priming protocols does not affect IVF outcomes. Poster presentation at the Society for Gynecologic Investigation Annual Meeting, San Diego, CA, March, 2012. Reprod Sci 2012; 19(3 Suppl): S47.
  • Aelion Brauer A, Mok-Lin E, Spandorfer S, Rosenwaks Z. The use of autologous endometrial co-culture (AECC) improves outcome in young poor responders with multiple failed IVF cycles. Oral presentation at the American Society for Reproductive Medicine Annual Meeting, Orlando, FL, October, 2011. Fertil Steril 2011; 96(3 Suppl): S67.
  • Aelion Brauer A, Mok-Lin E, Elias R, Goldschlag D, Rosenwaks Z. Gonadotropin stimulation of the patient with polycystic ovarian syndrome: a comparison of oral contraceptive pill/dual suppression lupron protocol versus oral contraceptive/antagonist protocol. Poster presentation at the American Society for Reproductive Medicine Annual Meeting, Orlando, FL, October, 2011. Fertil Steril 2011; 96(3 Suppl): S132.
  • Aelion Brauer A, Melnick A, Mok-Lin E, Spandorfer S. To be or not to be: the fate of a day three 4-cell embryo. Poster presentation at the American Society for Reproductive Medicine Annual Meeting, Orlando, FL, October, 2011. Fertil Steril 2011; 96(3 Suppl): S274.
  • Mok-Lin E, Aelion Brauer A, Davis O. Pregnancy outcomes in women with thin endometrium undergoing ovulation induction with clomiphene citrate. Poster presentation at the American Society for Reproductive Medicine Annual Meeting, Orlando, FL, October, 2011. Fertil Steril 2011; 96(3 Suppl): S269.
  • Mok-Lin E, Aelion Brauer A, Davis O. A thickened endometrial stripe on day 2 of antagonist protocols does not affect IVF outcomes. Poster presentation at the American Society for Reproductive Medicine Annual Meeting, Orlando, FL, October, 2011. Fertil Steril 2011; 96(3 Suppl): S178.
  • Aelion A, Elizabeth B, Shastri S, Grill E, Chung P, Rosenwaks Z. The Use of Complimentary Medical Therapies (CMT) in Infertility Patients. Oral presentation at the American Society for Reproductive Medicine Annual Meeting, Atlanta, GA, October 2009. Fertil Steril 2009; 92(3 Suppl): S33-S34.
  • Constantini-Ferrando MF, Rauch ER, Aelion A, Schattman GL, Spandorfer S, Rosenwaks Z. Can an Antimullarian Hormone Cutoff Level Predict Ovarian Response among Women with Poor Ovarian Reserve? Oral presentation at the American Society for Reproductive Medicine Annual Meeting, San Francisco, CA, October 2008. Fertil Steril 2008; 90 (3 Suppl): S32.

Q&A

I originally went into OB/GYN to practice Gynecologic Oncology. I loved surgery and women’s health, so I thought this specialty would be ideal in marrying my interests. As the intern, I spent much of my time on the GYN-Oncology service taking care of patients who were admitted to the hospital. I got to know them and their families well. I was intimately involved in their care plans. Their successes were my successes. Their failures were my failures. By nature, I am the ultimate optimist, never giving up hope. Sadly, I learned, that sometimes cancer wins. A good oncologist knows when to stop fighting. I could not accept this for my patients.

In my second year of residency, I spent more time in the operating room, often spending days with reproductive endocrinologists who did minimally invasive surgery. One of them invited me to join him in office hours. I loved it. Here is a field where optimism is the key ingredient to success. A field that allows me to mix my love of medicine, surgery, and persistent passion in helping almost anyone walking through the door achieve the most sought after treasure on earth, a family. I still maintain an interest in Oncology. I see young patients diagnosed with cancer often, but now I get to talk to them about the FUTURE and the life and family they will build AFTER cancer.

Spending time with my husband and our three girls makes me the happiest. Through all my years of training, and now practice, time is limited, so I try to enjoy any time I have with my family. I also love to dance and happened to marry someone who is pretty good at it as well! I also LOVE to cook and enjoy running or spinning for exercise. Exercise has always been the cornerstone of wellbeing for me.

My mom and, of course, my patients. Humans have this incredible ability to overcome adversity. I am always inspired by my patients who have been faced with incredible loss and are able to pick themselves up and move on to the next journey. Sometimes I feel that my patients are stronger than I am. They are truly my rocks.

My boulder is my mom. She was born in Poland to survivors of World War II. My mom always looks back on a wonderful upbringing in Poland. She moved her aging parents to Israel when she was in her 20s to go to medical school. In Israel, lectures are in Hebrew and textbooks are in English. My mom did not speak either. She would record the lectures, come home, take care of her parents, translate the lectures with a Polish-Hebrew dictionary, and study. This is how she got through medical school. Until this day, any time I have an important test or interview that I am nervous about she always says, “Well, at least you know the language!” She has inspired me to work hard and take every opportunity I am given.

The culture. Everything we do here is based on doing what is best for the patient. This idea is unfortunately getting harder and harder to find as the worlds of business and medicine intersect. Here, we are focused on practicing ethical, evidence-based medicine. This, along with best-in-class treatment options, transparency, and commitment to professionalism is what made me want to join this truly unique organization.

Listening is the most important place to start. Knowing where you came from is crucial to understanding where you are going. Next is having a plan. Understanding what your options are, the best and worst case scenarios, how to deal with them, and formulating a plan allows us to regain control of our struggle. In my mind, having a plan is very anxiety relieving and is extremely important even early in the journey.

Optimistic, passionate, social, and warm. I am a glass half full kind of gal. I always dream big. I feel strongly about my beliefs and fight for them. And I LOVE people.